<?xml-stylesheet type="text/xsl" href="varreports_v3.xsl"?><data_table name="MESA_AncilMesaLungA1AT" dataset_id="pht003088.v1" study_name="Multi-Ethnic Study of Atherosclerosis (MESA) Cohort" study_id="phs000209.v13" participant_set="3" date_created="11/05/2014"><description>MESA Lung A1AT Dataset: Alpha 1 antitrypsin for 185 case-control subjects from the MESA Lung Cohort.</description><variable id="phv00175966.v1.p3" var_name="sidno" calculated_type="string" reported_type="Numeric"><description>SHARE ID Number</description><total><subject_profile><sex><male>94</male><female>91</female></sex></subject_profile><stats><stat n="185" nulls="0"/></stats></total></variable><variable id="phv00175966.v1.p3.c1" var_name="sidno" calculated_type="string" reported_type="Numeric"><description>SHARE ID Number</description><total><subject_profile><sex><male>87</male><female>80</female></sex></subject_profile><stats><stat n="167" nulls="0"/></stats></total></variable><variable id="phv00175966.v1.p3.c2" var_name="sidno" calculated_type="string" reported_type="Numeric"><description>SHARE ID Number</description><total><subject_profile><sex><male>7</male><female>11</female></sex></subject_profile><stats><stat n="18" nulls="0"/></stats></total></variable><variable id="phv00175967.v1.p3" var_name="racegrp" calculated_type="string" reported_type="String"><description>RACE GROUP</description><total><subject_profile><sex><male>94</male><female>91</female></sex></subject_profile><stats><stat n="185" nulls="0"/><enum count="95">Hispanic</enum><enum count="90">Black</enum></stats></total></variable><variable id="phv00175967.v1.p3.c1" var_name="racegrp" calculated_type="string" reported_type="String"><description>RACE GROUP</description><total><subject_profile><sex><male>87</male><female>80</female></sex></subject_profile><stats><stat n="167" nulls="0"/><enum count="87">Hispanic</enum><enum count="80">Black</enum></stats></total></variable><variable id="phv00175967.v1.p3.c2" var_name="racegrp" calculated_type="string" reported_type="String"><description>RACE GROUP</description><total><subject_profile><sex><male>7</male><female>11</female></sex></subject_profile><stats><stat n="18" nulls="0"/><enum count="10">Black</enum><enum count="8">Hispanic</enum></stats></total></variable><variable id="phv00175968.v1.p3" var_name="a1at" calculated_type="decimal" units="mg/dL" reported_type="Numeric"><description>ALPHA-1 ANTI-TRYPSIN (mg/dL)</description><total><subject_profile><sex><male>89</male><female>88</female></sex></subject_profile><stats><stat n="177" nulls="8" mean="127.1" sd="22.77" median="126" min="68.8" max="284"/><example count="8">116</example><example count="6">137</example><example count="6">130</example><example count="6">132</example><example count="6">139</example><example count="5">119</example><example count="5">136</example><example count="5">108</example><example count="5">118</example><example count="5">126</example></stats></total></variable><variable id="phv00175968.v1.p3.c1" var_name="a1at" calculated_type="decimal" units="mg/dL" reported_type="Numeric"><description>ALPHA-1 ANTI-TRYPSIN (mg/dL)</description><total><subject_profile><sex><male>83</male><female>79</female></sex></subject_profile><stats><stat n="162" nulls="5" mean="127.5" sd="23.17" median="126" min="68.8" max="284"/><example count="8">116</example><example count="6">137</example><example count="5">136</example><example count="5">108</example><example count="5">130</example><example count="5">132</example><example count="5">139</example><example count="5">131</example><example count="4">119</example><example count="4">112</example></stats></total></variable><variable id="phv00175968.v1.p3.c2" var_name="a1at" calculated_type="decimal" units="mg/dL" reported_type="Numeric"><description>ALPHA-1 ANTI-TRYPSIN (mg/dL)</description><total><subject_profile><sex><male>6</male><female>9</female></sex></subject_profile><stats><stat n="15" nulls="3" mean="123.6" sd="18.23" median="123" min="94.5" max="154"/><example count="1">119</example><example count="1">97.7</example><example count="1">130</example><example count="1">94.5</example><example count="1">154</example><example count="1">98.2</example><example count="1">132</example><example count="1">117</example><example count="1">149</example><example count="1">118</example></stats></total></variable><variable id="phv00175969.v1.p3" var_name="a1atm" calculated_type="string" reported_type="Numeric"><description>ALPHA-1 ANTI-TRYPSIN: MISSING VALUE REASON</description><total><subject_profile><sex><male>2</male></sex></subject_profile><stats><stat n="2" nulls="183"/><enum code="1" count="2">REJECTED- LIPEMIC</enum></stats></total></variable><variable id="phv00175969.v1.p3.c1" var_name="a1atm" calculated_type="string" reported_type="Numeric"><description>ALPHA-1 ANTI-TRYPSIN: MISSING VALUE REASON</description><total><subject_profile><sex><male>1</male></sex></subject_profile><stats><stat n="1" nulls="166"/><enum code="1" count="1">REJECTED- LIPEMIC</enum></stats></total></variable><variable id="phv00175969.v1.p3.c2" var_name="a1atm" calculated_type="string" reported_type="Numeric"><description>ALPHA-1 ANTI-TRYPSIN: MISSING VALUE REASON</description><total><subject_profile><sex><male>1</male></sex></subject_profile><stats><stat n="1" nulls="17"/><enum code="1" count="1">REJECTED- LIPEMIC</enum></stats></total></variable><variable id="phv00175970.v1.p3" var_name="exam" calculated_type="enum_integer" reported_type="Numeric"><description>EXAM</description><total><subject_profile><sex><male>91</male><female>88</female></sex></subject_profile><stats><stat n="179" nulls="6" mean_count="44.75" sd="67.54" median_count="12.5" min_count="8" max_count="146"/><enum code="4" count="146">MESA EXAM 4</enum><enum code="3" count="14">MESA EXAM 3</enum><enum code="1" count="11">MESA FAMILY 1</enum><enum code="2" count="8">MESA EXAM 2</enum></stats></total></variable><variable id="phv00175970.v1.p3.c1" var_name="exam" calculated_type="enum_integer" reported_type="Numeric"><description>EXAM</description><total><subject_profile><sex><male>84</male><female>79</female></sex></subject_profile><stats><stat n="163" nulls="4" mean_count="40.75" sd="62.19" median_count="10.5" min_count="8" max_count="134"/><enum code="4" count="134">MESA EXAM 4</enum><enum code="3" count="12">MESA EXAM 3</enum><enum code="1" count="9">MESA FAMILY 1</enum><enum code="2" count="8">MESA EXAM 2</enum></stats></total></variable><variable id="phv00175970.v1.p3.c2" var_name="exam" calculated_type="enum_integer" reported_type="Numeric"><description>EXAM</description><total><subject_profile><sex><male>7</male><female>9</female></sex></subject_profile><stats><stat n="16" nulls="2" mean_count="5.333" sd="5.774" median_count="2" min_count="2" max_count="12"/><enum code="4" count="12">MESA EXAM 4</enum><enum code="3" count="2">MESA EXAM 3</enum><enum code="1" count="2">MESA FAMILY 1</enum></stats></total></variable><variable id="phv00175971.v1.p3" var_name="aliquot" calculated_type="string" reported_type="String"><description>ALIQUOT</description><total><subject_profile><sex><male>91</male><female>88</female></sex></subject_profile><stats><stat n="179" nulls="6"/><enum count="179">150 uLs</enum></stats></total></variable><variable id="phv00175971.v1.p3.c1" var_name="aliquot" calculated_type="string" reported_type="String"><description>ALIQUOT</description><total><subject_profile><sex><male>84</male><female>79</female></sex></subject_profile><stats><stat n="163" nulls="4"/><enum count="163">150 uLs</enum></stats></total></variable><variable id="phv00175971.v1.p3.c2" var_name="aliquot" calculated_type="string" reported_type="String"><description>ALIQUOT</description><total><subject_profile><sex><male>7</male><female>9</female></sex></subject_profile><stats><stat n="16" nulls="2"/><enum count="16">150 uLs</enum></stats></total></variable><variable id="phv00175972.v1.p3" var_name="pitype" calculated_type="string" reported_type="String"><description>PROTEINASE INHIBITOR (PI) TYPE</description><total><subject_profile><sex><male>94</male><female>91</female></sex></subject_profile><stats><stat n="185" nulls="0"/><example count="95">M1M1</example><example count="36">M1M3</example><example count="13">M1M2</example><example count="11">M1null/rare</example><example count="9">M2M3</example><example count="6">No sample in Exams 2-4</example><example count="4">M1S</example><example count="2">M1</example><example count="2">M2M2</example><example count="1">M1L variant</example></stats></total></variable><variable id="phv00175972.v1.p3.c1" var_name="pitype" calculated_type="string" reported_type="String"><description>PROTEINASE INHIBITOR (PI) TYPE</description><total><subject_profile><sex><male>87</male><female>80</female></sex></subject_profile><stats><stat n="167" nulls="0"/><example count="88">M1M1</example><example count="33">M1M3</example><example count="11">M1M2</example><example count="9">M2M3</example><example count="8">M1null/rare</example><example count="4">No sample in Exams 2-4</example><example count="4">M1S</example><example count="2">M2M2</example><example count="1">M1L variant</example><example count="1">M1</example></stats></total></variable><variable id="phv00175972.v1.p3.c2" var_name="pitype" calculated_type="string" reported_type="String"><description>PROTEINASE INHIBITOR (PI) TYPE</description><total><subject_profile><sex><male>7</male><female>11</female></sex></subject_profile><stats><stat n="18" nulls="0"/><enum count="7">M1M1</enum><enum count="3">M1null/rare</enum><enum count="3">M1M3</enum><enum count="2">No sample in Exams 2-4</enum><enum count="2">M1M2</enum><enum count="1">M1</enum></stats></total></variable></data_table>
